Redeye: Alzinova - Unique vaccine angle on Alzheimer’s

Report this content

Redeye initiates coverage of Alzinova, an early-stage biotech that develops a disease-modifying vaccine against Alzheimer’s disease.

Read more and download the Research Update:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.